Clinical Trial Update: Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza Vaccines [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating safety and immunogenicity of two doses of an H5N1 influenza vaccine in adults primed with adjuvanted or non-adjuvanted influenza vacc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza

Drugs mentioned

• H5N1 influenza vaccine (influenza vaccine H5N1)

Snippet

Sponsor: Novartis Vaccines | Conditions: Prophylaxis of Avian Influenza Vaccine | Phase 2 | Status: COMPLETED